Also trades as: 0IIM.L (LSE) · $vol 0M
ESPR NASDAQ
Esperion Therapeutics, Inc.
1W: +0.0%
1M: +55.0%
3M: -12.3%
YTD: -15.6%
1Y: +290.4%
3Y: +103.2%
5Y: -86.4%
$3.13
+0.00 (+0.00%)
Weekly Expected Move ±28.1%
$1
$2
$3
$4
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$650.8M
52W Range0.76-4.18
Volume6,939,683
Avg Volume10,972,821
Beta0.91
Dividend—
Analyst Ratings
Company Info
CEOSheldon L. Koenig
Employees304
SectorHealthcare
IndustryBiotechnology
IPO Date2013-06-26
Websiteesperion.com
3891 Ranchero Drive
Ann Arbor, MI 48108
US
Ann Arbor, MI 48108
US
734 887 3903
About Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Latest News
ESPR Stock Surges 44% in a Month: Here's What You Need to Know
Halper Sadeh LLC is Investigating Whether SILA, ESPR, CRBG, EQH are Obtaining Fair Deals for their Shareholders
Halper Sadeh LLC is Investigating Whether SILA, LSTA, ESPR are Obtaining Fair Deals for their Shareholders
What's Going On With Esperion Therapeutics Stock On Monday?
Key deals this week: Organon, ARC Resources, Nebius, Eli Lilly and more
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Looker Benjamin | S-Sale | 5,708 | $2.70 | 2026-03-17 |
| Koenig Sheldon L. | S-Sale | 25,578 | $2.72 | 2026-03-17 |
| Halladay Benjamin | S-Sale | 6,424 | $2.71 | 2026-03-17 |
| Looker Benjamin | A-Award | 300,840 | — | 2026-03-13 |
| Looker Benjamin | A-Award | 269,230 | $2.44 | 2026-03-13 |